Whittier Trust CO Abb Vie Inc. Transaction History

Whittier Trust CO

$6.97 Billion
Q2 2024

A detailed history of Whittier Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Whittier Trust CO holds 244,326 shares of ABBV stock, worth $46.9 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

244,326

Previous 241,822 1.04%

Holding current value

$46.9 Million

Previous $44 Million 4.83%

% of portfolio

0.6%

Previous 0.65%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $387,594 - $452,623	2,504 Added 1.04%	244,326 $41.9 Million
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $11.2 Million - $12.8 Million	70,206 Added 40.91%	241,822 $44 Million
Q4 2023 Jan 11, 2024	BUY	$137.6 - $154.97 $210,252 - $236,794	1,528 Added 0.9%	171,616 $26.6 Million
Q3 2023 Oct 27, 2023	BUY	$133.59 - $154.65 $106,604 - $123,410	798 Added 0.47%	170,088 $25.4 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $417,141 - $519,105	-3,148 Reduced 1.83%	169,290 $22.8 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $19,956 - $22,982	-138 Reduced 0.08%	172,438 $27.5 Million
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $146,470 - $175,656	-1,059 Reduced 0.61%	172,576 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $1.12 Million - $1.29 Million	-8,375 Reduced 4.6%	173,635 $23.3 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $91,242 - $115,998	-663 Reduced 0.36%	182,010 $27.9 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $126,568 - $157,036	-959 Reduced 0.52%	182,673 $29.6 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $344,957 - $436,471	3,211 Added 1.78%	183,632 $24.9 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $64,159 - $72,830	603 Added 0.34%	180,421 $19.5 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $421,892 - $470,012	4,010 Added 2.28%	179,818 $20.3 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $102,606 - $112,957	-1,003 Reduced 0.57%	175,808 $19 Million
Q4 2020 Jan 29, 2021	SELL	$80.49 - $108.67 $1.17 Million - $1.58 Million	-14,569 Reduced 7.61%	176,811 $18.9 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $417,264 - $489,731	4,857 Added 2.6%	191,380 $16.8 Million
Q2 2020 Jul 10, 2020	BUY	$73.37 - $98.18 $1.85 Million - $2.48 Million	25,228 Added 15.64%	186,523 $18.3 Million
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $21,543 - $32,661	-334 Reduced 0.21%	161,295 $12.3 Million
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $16,878 - $21,118	-234 Reduced 0.14%	161,629 $14.3 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $74,127 - $89,122	1,177 Added 0.73%	161,863 $12.3 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $13,534 - $17,299	-206 Reduced 0.13%	160,686 $11.7 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $3.8 Million - $4.48 Million	-49,319 Reduced 23.46%	160,892 $13 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $157,334 - $194,036	-2,021 Reduced 0.95%	210,211 $19.4 Million
Q3 2018 Oct 23, 2018	SELL	$88.91 - $98.84 $387,647 - $430,942	-4,360 Reduced 2.01%	212,232 $20.1 Million
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $5.81 Million - $6.87 Million	-64,700 Reduced 23.0%	216,592 $20.1 Million
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $5.42 Million - $6.41 Million	60,336 Added 27.31%	281,292 $15.9 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $284,218 - $380,595	-3,089 Reduced 1.38%	220,956 $20.9 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $1.32 Million - $1.44 Million	-14,700 Reduced 6.16%	224,045 $21.7 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $16.7 Million - $21.3 Million	238,745	238,745 $21.2 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $339B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Account

Whittier Trust CO Abb Vie Inc. Transaction History